Anticoagulant reversal agent that has been cancelled
From the article
Andexxa—an anticoagulant reversal agent for two drugs—has been discontinued as of December 22, 2025. If patients are taking these drugs and have significant bleeding, what do you do? Join us in Medical History Mysteries.
Continue reading on Dentistry IQYou might also wanna read
Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns
reuters.com·1mo ago
AstraZeneca to pull breast cancer and endometriosis drug Zoladex from Australian market in November
AstraZeneca is removing the breast cancer and endometriosis drug Zoladex from Australia's Pharmaceutical Benefits Scheme (PBS) and private m
theguardian.com·28d agoEndoscopic Application of Hemostatic Drug Powder in Lower Gastrointestinal Bleeding: A Pilot Study
clinicaltrials.gov·8d ago
BREAKING: HHS Terminates the COVID-19 Emergency Use Authorization Declarations Covering mRNA Shots, Drugs, and Biologics
Courageous Discourse·8d ago
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
reuters.com·1mo ago
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
reuters.com·1mo ago
A Study to Evaluate Luspatercept Utilization in Patients With Lower Risk Myelodysplastic Syndromes or Beta-thalassemia
clinicaltrials.gov·7d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.